Inventor · disambiguated record
Adam Elhofy
Also filed as: ELHOFY ADAM
1 granted patent·8 pending applications·2 citations·filing 2012–2023
20Inventor score
Files withCOUR PHARMACEUTICALS DEV COMPANY INC4ESSENTIAL PHARMACEUTICALS LLC2ONCOUR PHARMA INC2BIO-ESS LABORATORIES LLC1
Top patents by PatentIndex Score
9 records- 0168US9637721B2Media for cell cultureESSENTIAL PHARMACEUTICALS LLC·Filed 2014·Granted May 2, 2017·2 cites·8 claims
- 0257US2025367274A1Tolerizing Immune Modifying Nanoparticles for Overcoming the Immunogenicity of Therapeutic Vectors and ProteinsCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2023·Application pending·0 cites
- 0351US2024197866A1Treatment of peanut allergy with tolerizing nanoparticlesCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2022·Application pending·0 cites
- 0451US2024408186A1Treatment of primary biliary cholangitis (pbc) with tolerizing nanoparticlesCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2022·Application pending·0 cites
- 0550US2024201187A1Method of Tracking Maintenance of Immunological ToleranceCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2022·Application pending·0 cites
- 0650US2025170066A1Treatment of solid tumors with negatively charged particlesONCOUR PHARMA INC·Filed 2023·Application pending·0 cites
- 0741US2022257768A1Treatment of immune evasive tumorsONCOUR PHARMA INC·Filed 2020·Application pending·0 cites
- 0836US2017198251A1Media for Cell CultureBIO-ESS LABORATORIES LLC·Filed 2017·Application pending·0 cites
- 0927US2013130373A1Kit Comprising Serum Replacement and Labile FactorsESSENTIAL PHARMACEUTICALS LLC·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Adam Elhofy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →